Ventriculoperitoneal (VP) Shunts

Share This Post

de Ribaupierre, S., Rilliet, B., Vernet, O. et al

1. Introduction

A ventriculoperitoneal (VP) shunt is a surgically implanted medical device designed to treat hydrocephalus, a neurological condition characterized by an accumulation of cerebrospinal fluid (CSF) within the brain’s ventricles. Excessive CSF can increase intracranial pressure, potentially leading to brain damage or even death. The VP shunt consists of a flexible, hollow tube that drains the excess fluid from the ventricles in the brain to the peritoneal cavity in the abdomen, where it is safely absorbed by the body.

Examples of VP shunts available in the market include the Medtronic Strata® Adjustable Valve system, the Codman® Hakim® Programmable Valve system, the Sophysa Polaris™ Adjustable Valve system, the Chhabra Shunt System by Surgiwear, the Cerebrospinal Fluid (CSF) Management System by CereDRAIN, and the PediGAV® and ProGAV® systems by Aesculap.

2. Purpose and Function

The primary purpose of a VP shunt is to relieve intracranial pressure resulting from excess CSF. By maintaining normal fluid levels in the brain, the shunt helps to preserve brain function, prevent neurological damage, and alleviate symptoms associated with hydrocephalus.

3. Indications

VP shunts are indicated for patients diagnosed with hydrocephalus, which can result from various factors such as congenital abnormalities, brain tumors, infections, hemorrhage, or traumatic brain injury. The treatment is recommended when other less invasive methods, like medication or temporary measures, fail to provide relief or are unsuitable for the patient.

4. Mechanism of Action

A VP shunt works by diverting excess CSF from the ventricles in the brain to the peritoneal cavity. The shunt system typically comprises three main components: a ventricular catheter, a valve, and a distal catheter. The ventricular catheter is inserted into the brain’s ventricle, while the distal catheter extends to the peritoneal cavity.

The valve, positioned between the two catheters, regulates the flow of CSF and prevents backflow, ensuring a controlled and safe drainage process.Shunt valves play a crucial role in the management of hydrocephalus by regulating the flow of cerebrospinal fluid (CSF) from the brain to the peritoneal cavity or another drainage site such as Pleural cavity.

There are several types of shunt valves, each with unique characteristics and functionalities. Some common types include:

  • Fixed-pressure valves: These valves maintain a constant pressure setting to control the flow of CSF. They are pre-set by the manufacturer and cannot be adjusted after implantation. The Medtronic Delta Valve system is an example of a fixed-pressure valve.
  • Adjustable valves: Adjustable valves allow the pressure settings to be changed non-invasively after implantation. This flexibility enables healthcare providers to fine-tune the valve settings to meet individual patient needs. Examples of adjustable valve systems include the Medtronic Strata Adjustable Valve system, the Codman Hakim Programmable Valve system, and the Sophysa Polaris Adjustable Valve system.
  • Gravity-assisted valves: Gravity-assisted valves, also known as siphon-control valves, are designed to prevent over-drainage of CSF when the patient is in an upright position. These valves incorporate a mechanism that counteracts the effects of gravity to maintain proper CSF flow. An example of a gravity-assisted valve is the AesculapProGAV system, which features an integrated gravitational unit.
  • Flow-regulating valves: Flow-regulating valves maintain a constant flow rate of CSF, regardless of changes in pressure. This type of valve is less commonly used but can be beneficial in specific situations where constant flow is needed.
  • Combination valves: Combination valves incorporate features of multiple valve types to address specific patient needs. For instance, a valve may combine adjustable pressure settings with gravity-assisted functionality to optimize CSF flow management.

5. Shunt Systems available

There are several shunt systems available in the market designed to treat hydrocephalus. These systems can vary in terms of materials, valve designs, and other features. Some examples include:

  • Codman Hakim Programmable Valve system: Codman, a division of Johnson & Johnson, offers the Codman Hakim Programmable Valve system. This shunt system features a programmable valve that allows the surgeon to adjust the pressure settings non-invasively after implantation.
  • Medtronic Strata Adjustable Valve system: Medtronic is a leading global medical device company that offers a range of VP shunt systems. The Strata Adjustable Valve system provides adjustable pressure settings to better tailor the shunt to individual patient needs.
  • Medtronic Delta Valve system: Medtronic is a leading global medical device company that offers a range of VP shunt systems. The Delta Valve system is a non-adjustable, fixed-pressure valve designed to provide reliable and consistent pressure control.
  • Sophysa Polaris Adjustable Valve system: Sophysa, a French company, produces the Polaris Adjustable Valve system. This shunt system offers a wide range of pressure settings and is MRI-resistant, allowing patients to undergo MRI scans without compromising the shunt’s function.
  • Chhabra Shunt System: The Chhabra Shunt System, manufactured by Surgiwear in India, is a cost-effective solution designed to meet the needs of patients with hydrocephalus.
  • CereDRAIN Cerebrospinal Fluid (CSF) Management System: CereDRAIN, an Indian company, offers a shunt system for the management of CSF in patients with hydrocephalus. This system is designed to provide effective drainage and ensure patient safety.
  • AesculapPediGAV and ProGAV systems: Aesculap, a division of B. Braun, offers the PediGAV and ProGAV shunt systems. These systems are designed for use in pediatric and adult patients, respectively, and feature advanced valve technology for precise pressure control.

Please note that this list is not exhaustive, and there may be other shunt systems available in the market as well as all shunt systems may not be available everywhere.

6. Procedure for placing Implant

The VP shunt placement procedure is performed under general anesthesia. The surgeon first creates a small incision behind the ear or on the scalp to access the brain’s ventricle. The ventricular catheter is then carefully inserted into the targeted ventricle. Next, a small incision is made in the abdomen (or other drainage site), and the distal catheter is tunneled under the skin and inserted into the potential absorption site. The valve is placed between the two catheters and adjusted to ensure proper CSF flow. The incisions are then closed, and the patient is moved to a recovery area.

7. Potential Risks

As with any surgery, there are potential risks associated with VP shunt placement. These may include infection, bleeding, damage to surrounding tissue, or an allergic reaction to the shunt material. Other risks specific to VP shunts include shunt malfunction (blockage, disconnection, or valve failure), over-drainage, or under-drainage of CSF, which may require further surgical intervention.

8. Benefits and Effectiveness

VP shunts can significantly improve the quality of life for patients with hydrocephalus. They effectively alleviate symptoms such as headaches, nausea, vomiting, vision problems, impaired cognitive function, and motor difficulties. By preventing further brain damage and reducing intracranial pressure, VP shunts contribute to better overall neurological health.

9. Post ImplantCare & Follow up

Regular follow-up appointments with the healthcare provider are essential to monitor the shunt’s function and ensure its continued effectiveness. Patients may need periodic imaging tests, such as CT scans or MRIs, to evaluate the shunt’s position and performance. In case of any complications or signs of shunt malfunction, immediate medical attention is required. Patients should also be aware of the signs of infection, such as fever, redness, or swelling around the incision site, and seek medical care if necessary.

10. Alternatives to VP Shunt

Alternative treatments for hydrocephalus include endoscopic third ventriculostomy (ETV), a surgical procedure that creates a new pathway for CSF to flow without the need for a shunt. In this procedure, a small hole is made in the floor of the third ventricle, allowing CSF to bypass the obstruction and flow directly into the subarachnoid space. However, not all patients are suitable candidates for ETV, and the procedure may not be as effective in certain cases, such as those involving communicating hydrocephalus.

11. Summary

VP shunts are essential devices used to treat hydrocephalus by diverting excess CSF from the brain to the peritoneal cavity. Examples of VP shunts include the Medtronic Strata® Adjustable Valve system, the Codman® Hakim® Programmable Valve system, the Sophysa Polaris™ Adjustable Valve system,Medtronic Delta Valve systemthe Chhabra Shunt System by Surgiwear, the Cerebrospinal Fluid (CSF) Management System by CereDRAIN, and the PediGAV® and ProGAV® systems by Aesculap. While the procedure can significantly improve patients’ quality of life and prevent further brain damage, it is not without risks, and regular follow-up care is crucial to ensure the shunt’s proper functioning. Alternative treatments, such as ETV, may be suitable for some patients, but their effectiveness depends on the specific type and cause of hydrocephalus.

12. Disclaimer

This article provides general information about healthcare topics to help individuals make informed decisions and connect with medical professionals for support. However, it is important to note that the information in this article is not a substitute for professional medical advice, diagnosis, or treatment. It is recommended to always seek the advice of a qualified healthcare provider for any medical questions or concerns. Reliance on any information provided in this article is solely at your own risk. If you are interested in scheduling an appointment with a qualified specialist in Pediatric neurosurgery, you can contact us via phone or message on Telegram / WhatsApp at +91 8109 24 7 365.

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Cranio-facial Fibrous Dysplasia

1. Introduction Craniofacial fibrous dysplasia (CFD) is a rare bone disorder that affects the face and skull. It is caused by a genetic mutation that

Want help with Pediatric Neurosurgical Concerns?

Join Our Community Online

× How can I help you?